Special monitoring may be needed for diabetes medications (though AOD-9604 doesnt affect glucose metabolism), cardiovascular drugs, thyroid medications, or other growth hormone-related therapies
Standard reconstitution steps 01 Inspect the vial Confirm label, vial size, and that the powder cake is intact
Walker 2020 AOD-9604 Dosage Protocol: Subcutaneous Injection Timing For subcutaneous research use, 250500 mcg once daily is the standard starting range
Why people explore AOD 9604/MOTS-C AOD 9604 drives lipolysis to break down existing fat stores
They recognize that clinical trials showed modest effects (average 2.6 kg over 12 weeks in responders), appreciate that individual response varies significantly, commit to proper nutrition and exercise foundations, and accept that the peptide is used for research purposes under medical supervision
Optimal timing enhances effectiveness while poor timing can waste a significant portion of each dose